This protocol applies to children under 16 years of age presenting with epilepsy characterised by absence seizures. Onset and offset of altered awareness occurs abruptly; oral and manual automatisms are common, while myoclonus of the limbs is rare.
Evidence-based guidelines recommend initiating monotherapy with a single Level A first-line agent as the first step in managing absence seizures in this age group.
The specific agent selection and titration schedule — including the complete regimen — are detailed in the full structured protocol.